Momentum towards simplifying and expanding treatment for chronic hepatitis B: The body of evidence continues to grow: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial” [PDF]
Clinical and Molecular HepatologyRobert J. Wong
doaj +1 more source
Current status of drug therapy for chronic hepatitis B. [PDF]
World J GastroenterolJiang C, Zhang ZH, Li JX.
europepmc +1 more source
Interferon in clinically stable, replicative chronic hepatitis B: Good news for some
, 1991 R.S. Koff
openalex +1 more source
Nanoparticle-mediated SIRT1 inhibition suppresses M2 macrophage polarization and hepatocarcinogenesis in chronic hepatitis B. [PDF]
J NanobiotechnologyZhang H +9 more
europepmc +1 more source
Beyond the liver: well-being as the bridge between fatigue and quality of life in chronic hepatitis B patients. [PDF]
Front Public HealthZheng C +7 more
europepmc +1 more source
Reply to: "Understanding virologic heterogeneity in chronic hepatitis B treatment". [PDF]
JHEP RepMatthews PC +3 more
europepmc +1 more source
Xalnesiran with or without an immunomodulator in chronic hepatitis B: still a challenge in functional cure. [PDF]
Hepatobiliary Surg NutrTang Q, Xue Y, Hu P.
europepmc +1 more source
Expanding treatment indications in chronic hepatitis B: Should we treat all patients? [PDF]
Hepatol IntHui RW +4 more
europepmc +1 more source
Accelerators of chronic hepatitis B fibrosis cirrhosis CCND1 gene expression and promoter hypomethylation. [PDF]
Sci RepChen N +7 more
europepmc +1 more source
Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients. [PDF]
Sci RepLim J, Lee HY, Sang H, Jeong SJ, Kim HI.
europepmc +1 more source